Dual-layer spectral detector computed tomography for improving the demonstration of the communication between intraductal papillary mucinous neoplasms and pancreatic duct

双层光谱探测器计算机断层扫描技术用于提高导管内乳头状黏液性肿瘤与胰管之间交通的显示效果

阅读:2

Abstract

BACKGROUND: Ductal communication is a critical discriminator for differentiating intraductal papillary mucinous neoplasms (IPMNs) from other pancreatic cystic neoplasms. This study evaluated dual-layer spectral detector computed tomography (DLCT)-derived virtual monoenergetic images (VMIs) for displaying IPMN-duct communication compared to conventional polyenergetic images (PEIs) and magnetic resonance cholangiopancreatography (MRCP). METHODS: A total of 35 patients with IPMNs from August 2021 to September 2023 were enrolled in this cross-sectional study. PEIs and VMIs (40/50/60/70 keV) were reconstructed at arterial phase (AP) and portal venous phase (PVP). Quantitative metrics [attenuation difference (AD), signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR)] for pancreatic parenchyma, lesions, and ducts were measured. Two radiologists independently assessed qualitative parameters (5-point Likert scales) and duct communication. Statistical analyses included analysis of variance (ANOVA) test, Friedman test, inter-reader agreement (kappa), and McNemar's test. RESULTS: Quantitative analysis demonstrated that VMI 40 keV achieved the highest AD, SNR, and CNR for lesions/ducts (P<0.001 vs. PEI), with lesion AD at AP increasing >130% [224.1 vs. 94.8 Hounsfield units (HU); P<0.001]. VMI 40-50 keV provided significantly higher AD and CNR than VMI 60-70 keV (P<0.01). Qualitatively, VMI 40 keV scored optimally (median =5 across all parameters; P<0.001 vs. PEI) with excellent inter-reader agreement (κ=0.78-0.81). DLCT at VMI 40 keV displayed ductal communication in all 30 patients (100%), whereas MRCP demonstrated 28/30 cases (93.3%, P=0.500). CONCLUSIONS: VMI 40-50 keV significantly improved quantitative and qualitative image quality in the display of IPMN-duct communication over PEI and higher-keV VMIs, achieving diagnostic equivalence to MRCP. This supports DLCT as a practical alternative when MRCP is contraindicated or unavailable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。